Consumers who have taken popular weight-loss drugs are far more likely than others to expect the medications to have a major impact on food preferences and habits, according to a survey.
Some 43% of consumers who have had experience with GLP-1 medications such as Ozempic say they expect the drugs to significantly affect dietary preferences and food purchasing decisions. Nearly 41% expect somewhat of an impact, says the Gardner Food and Agricultural Policy Survey conducted by researchers at the University of Illinois and Purdue University.
It’s easy to be “in the know” about what’s happening in Washington, D.C. Sign up for a FREE month of Agri-Pulse news! Simply click here.
By comparison, only 14% of consumers who haven’t taken the drugs expect them to have a significant impact on diets and buying habits. About 39% of those consumers say the drugs could somewhat impact the public.
Some 20% of those surveyed said they had taken the drugs in the past or were taking them now.
For more news, go to www.Agri-Pulse.com.
